Qiu, J., Wang, C., Wu, Z., He, W., Yuan, Y., Huang, Z., Li, B., Yuan, Y. (2026). Nivolumab and ipilimumab as second or later line therapy in hepatocellular carcinoma: A retrospective study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16167